Paul Tudor Jones’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Paul Tudor Jones's ICPT Position: Q4 2023 in Review

Paul Tudor Jones sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 25,000 shares — an estimated $464K sold.

Paul Tudor Jones first reported a position in ICPT in Q1 2015 and held it in 3 quarters. The position peaked at $945K in Q1 2015. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

• Paul Tudor Jones reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
• Paul Tudor Jones sold 25,000 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $464K.
• Paul Tudor Jones first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
• Paul Tudor Jones's Intercept Pharmaceuticals, Inc. position peaked at $945K in Q1 2015.
• 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Tudor Investment Corp's 13F filing for Q4 2023, filed 14 Feb 2024.